UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 273

Sortiert nach

Recent advances in medical therapy for metastatic urothelial cancer

International journal of clinical oncology, 2018-08, Vol.23 (4), p.599-607

2018

Volltextzugriff (PDF)

Biomarkers to predict prognosis and response to checkpoint inhibitors

International journal of clinical oncology, 2017-08, Vol.22 (4), p.629-634

2017

Volltextzugriff (PDF)

Nivolumab versus everolimus in advanced renal cell carcinoma: Japanese subgroup 3-year follow-up analysis from the Phase III CheckMate 025 study

Japanese journal of clinical oncology, 2019-06, Vol.49 (6), p.506-514

2019

Volltextzugriff (PDF)

A multicenter retrospective study of nivolumab monotherapy in previously treated metastatic renal cell carcinoma patients: interim analysis of Japanese real-world data

International journal of clinical oncology, 2020-08, Vol.25 (8), p.1533-1542

2020

Volltextzugriff (PDF)

Outcomes of intensity-modulated radiation therapy for intermediate- or high-risk prostate cancer: a single-institutional study

Japanese journal of clinical oncology, 2022-02, Vol.52 (2), p.170-178

2022

Volltextzugriff (PDF)

Therapeutic inhibition of mitochondrial function induces cell death in starvation-resistant renal cell carcinomas

Scientific reports, 2016-05, Vol.6 (1), p.25669-25669, Article 25669

2016

Volltextzugriff (PDF)

Clinical features and outcomes of metastatic pheochromocytoma treated by cytotoxic chemotherapy

Endocrine Journal, 2021, Vol.68(6), pp.671-681

2021

Volltextzugriff (PDF)

Nivolumab versus everolimus in advanced renal cell carcinoma: Japanese subgroup analysis from the CheckMate 025 study

Japanese journal of clinical oncology, 2017-07, Vol.47 (7), p.639-646

2017

Volltextzugriff (PDF)

Early C-reactive protein kinetics predict survival of patients with advanced urothelial cancer treated with pembrolizumab

Cancer Immunology, Immunotherapy, 2021-03, Vol.70 (3), p.657-665

2021

Volltextzugriff (PDF)

A novel fusion of HNRNPA1 – ALK in inflammatory myofibroblastic tumor of urinary bladder

Human pathology, 2017-11, Vol.69, p.96-100

2017

Volltextzugriff (PDF)

Real-world use of enzalutamide in men with nonmetastatic castration-resistant prostate cancer in Japan

International journal of clinical oncology, 2022-02, Vol.27 (2), p.418-426

2022

Volltextzugriff (PDF)

Early Serum and Hematological Responses to Pembrolizumab Therapy as Predictors of Survival in Metastatic Urothelial Cancer

Anticancer research, 2022-04, Vol.42 (4), p.2045-2051

2022

Volltextzugriff (PDF)

Diagnostic performance and safety of NMK36 (trans-1-amino-3-[18F]fluorocyclobutanecarboxylic acid)-PET/CT in primary prostate cancer: multicenter Phase IIb clinical trial

Japanese journal of clinical oncology, 2016-02, Vol.46 (2), p.152-162

2016

Volltextzugriff (PDF)

Tumor B7-H3 expression in diagnostic biopsy specimens and survival in patients with metastatic prostate cancer

Prostate cancer and prostatic diseases, 2021-09, Vol.24 (3), p.767-774

2021

Volltextzugriff (PDF)

Identification of anaplastic lymphoma kinase fusions in renal cancer

Cancer, 2012-09, Vol.118 (18), p.4427-4436

2012

Volltextzugriff (PDF)

Serum and hematologic responses after three cycles of cabazitaxel therapy as predictors of survival in castration-resistant prostate cancer

Cancer chemotherapy and pharmacology, 2021-09, Vol.88 (3), p.525-531

2021

Volltextzugriff (PDF)

Clinical Outcomes and Prognostic Factors in Nonmetastatic Castration-Resistant Prostate Cancer Treated with Androgen Receptor Signaling Inhibitors Therapy

Cancers, 2024-08, Vol.16 (15), p.2659

2024

Volltextzugriff (PDF)

Adult Xp11 Translocation Renal Cell Carcinoma Diagnosed by Cytogenetics and Immunohistochemistry

Clinical cancer research, 2009-02, Vol.15 (4), p.1170-1176

2009

Volltextzugriff (PDF)

TRIB1 Supports Prostate Tumorigenesis and Tumor-Propagating Cell Survival by Regulation of Endoplasmic Reticulum Chaperone Expression

Cancer research (Chicago, Ill.), 2014-09, Vol.74 (17), p.4888-4897

2014

Volltextzugriff (PDF)

Diagnostic performance of a computer-assisted diagnosis system for bone scintigraphy of newly developed skeletal metastasis in prostate cancer patients: search for low-sensitivity subgroups

Annals of nuclear medicine, 2017-08, Vol.31 (7), p.521-528

2017

Volltextzugriff (PDF)

Japanese subgroup analysis of EV‐301: An open‐label, randomized phase 3 study to evaluate enfortumab vedotin versus chemotherapy in subjects with previously treated locally advanced or metastatic urothelial carcinoma

Cancer medicine (Malden, MA), 2023-02, Vol.12 (3), p.2761-2771

2023

Volltextzugriff (PDF)

External validation of the Briganti 2019 nomogram to identify candidates for extended pelvic lymph node dissection among patients with high-risk clinically localized prostate cancer

International journal of clinical oncology, 2021-09, Vol.26 (9), p.1736-1744

2021

Volltextzugriff (PDF)

Tumor shrinkage patterns of nivolumab monotherapy in metastatic renal cell carcinoma

International journal of urology, 2022-10, Vol.29 (10), p.1181-1187

2022

Volltextzugriff (PDF)

Efficacy and safety profile of nivolumab for Japanese patients with metastatic renal cell cancer

International journal of clinical oncology, 2020, Vol.25 (1), p.151-157

2020

Volltextzugriff (PDF)

Renal function outcome after selective bladder-preserving tetramodality therapy consisting of maximal transurethral resection, induction chemoradiotherapy and consolidative partial cystectomy in comparison with radical cystectomy for patients with muscle-invasive bladder cancer: a two-centre retrospective study

Japanese journal of clinical oncology, 2023-03, Vol.53 (3), p.263-269

2023

Volltextzugriff (PDF)

1 – 25 von 273

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(199)
Mit Volltextzugriff
(261)

Publikationsform

Artikel
(256)
Berichte
(17)

Sprache

Englisch
(238)
Japanisch
(81)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Recent advances in medical therapy for metastatic urothelial cancer

Biomarkers to predict prognosis and response to checkpoint inhibitors

Nivolumab versus everolimus in advanced renal cell carcinoma: Japanese subgroup 3-year follow-up analysis from the Phase III CheckMate 025 study

A multicenter retrospective study of nivolumab monotherapy in previously treated metastatic renal cell carcinoma patients: interim analysis of Japanese real-world data

Outcomes of intensity-modulated radiation therapy for intermediate- or high-risk prostate cancer: a single-institutional study

Therapeutic inhibition of mitochondrial function induces cell death in starvation-resistant renal cell carcinomas

Clinical features and outcomes of metastatic pheochromocytoma treated by cytotoxic chemotherapy

Nivolumab versus everolimus in advanced renal cell carcinoma: Japanese subgroup analysis from the CheckMate 025 study

Early C-reactive protein kinetics predict survival of patients with advanced urothelial cancer treated with pembrolizumab

A novel fusion of HNRNPA1 – ALK in inflammatory myofibroblastic tumor of urinary bladder

Real-world use of enzalutamide in men with nonmetastatic castration-resistant prostate cancer in Japan

Early Serum and Hematological Responses to Pembrolizumab Therapy as Predictors of Survival in Metastatic Urothelial Cancer

Diagnostic performance and safety of NMK36 (trans-1-amino-3-[18F]fluorocyclobutanecarboxylic acid)-PET/CT in primary prostate cancer: multicenter Phase IIb clinical trial

Tumor B7-H3 expression in diagnostic biopsy specimens and survival in patients with metastatic prostate cancer

Identification of anaplastic lymphoma kinase fusions in renal cancer

Serum and hematologic responses after three cycles of cabazitaxel therapy as predictors of survival in castration-resistant prostate cancer

Clinical Outcomes and Prognostic Factors in Nonmetastatic Castration-Resistant Prostate Cancer Treated with Androgen Receptor Signaling Inhibitors Therapy

Adult Xp11 Translocation Renal Cell Carcinoma Diagnosed by Cytogenetics and Immunohistochemistry

TRIB1 Supports Prostate Tumorigenesis and Tumor-Propagating Cell Survival by Regulation of Endoplasmic Reticulum Chaperone Expression

Diagnostic performance of a computer-assisted diagnosis system for bone scintigraphy of newly developed skeletal metastasis in prostate cancer patients: search for low-sensitivity subgroups

Japanese subgroup analysis of EV‐301: An open‐label, randomized phase 3 study to evaluate enfortumab vedotin versus chemotherapy in subjects with previously treated locally advanced or metastatic urothelial carcinoma

External validation of the Briganti 2019 nomogram to identify candidates for extended pelvic lymph node dissection among patients with high-risk clinically localized prostate cancer

Tumor shrinkage patterns of nivolumab monotherapy in metastatic renal cell carcinoma

Efficacy and safety profile of nivolumab for Japanese patients with metastatic renal cell cancer

Suchergebnisse filtern